G1 THERAPEUTICS INC

CUSIP: 3621LQ109 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 370,000 Value ($000) $2,009 Avg Close Range
Q3 2022
Shares 370,000 Value ($000) $3,944 Avg Close Range
Q2 2022
Shares 316,137 Value ($000) $1,562 Avg Close Range
Q1 2022
Shares 316,137 Value ($000) $2,403 Avg Close Range
Q4 2021
Shares 325,000 Value ($000) $3,400 Avg Close Range
Q3 2021
Shares 325,000 Value ($000) $4,362 Avg Close Range
Q2 2021
Shares 325,000 Value ($000) $7,131 Avg Close Range
Q1 2021
Shares 325,000 Value ($000) $7,820 Avg Close Range
Q4 2020
Shares 240,000 Value ($000) $4,318 Avg Close Range
Q3 2020
Shares 190,000 Value ($000) $2,195 Avg Close Range
Q2 2020
Shares 190,000 Value ($000) $4,609 Avg Close Range
Q1 2020
Shares 250,172 Value ($000) $2,757 Avg Close Range
Q4 2019
Shares 263,400 Value ($000) $6,962 Avg Close Range
Q3 2019
Shares 535,657 Value ($000) $12,202 Avg Close Range
Q2 2019
Shares 274,274 Value ($000) $8,409 Avg Close Range
Q1 2019
Shares 212,169 Value ($000) $3,522 Avg Close Range
Q4 2018
Shares 172,820 Value ($000) $3,310 Avg Close Range